CPChintan Pandya

Chintan Pandya

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chintan Pandya has a total of 62 co-authors. Here are the top co-authors by number of shared publications:

  • Hadi Kharrazi

    Department of Health Policy and Management, Center for Population Health IT, Johns Hopkins School of Public Health, Baltimore, MD

    3 shared publications
  • Jonathan P. Weiner

    Center for Population Health Information Technology, Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States

    3 shared publications
  • Christopher Kitchen

    Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, 2024 E Monument Street, Baltimore, MD, United States, 1 3015310011

    2 shared publications
  • Elham Hatef

    Division of General Internal Medicine, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland

    2 shared publications
  • Hadi Kharrazi

    Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States

    2 shared publications
  • Klaus W. Lemke

    Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, 2024 E Monument Street, Baltimore, MD, United States, 1 3015310011

    2 shared publications

Latest Publications

  • Open Access

    Cost and utilization outcomes of pharmacist-led medication therapy optimization in a Medicare ACO population

    by Hazem F Elewa, Joseph F Levy, Chintan Pandya, Steven E Goldberg, Travis A Morgan

    Introduction: Medication-related problems are a persistent source of avoidable spending among Medicare beneficiaries, presenting an important opportunity to improve the quality of care for seniors and reduce financial burden on the Medicare program. Methods: We evaluated a pharmacist-led medication therapy optimization (MTO) program implemented in a Medicare accountable care organization population using a regression-adjusted difference-in-differences design with propensity score matching. The analysis included 1003 treated members and 14 031 matched controls contributing 334 531 member-months of claims data (2022-2025). The MTO program combined pharmacogenomic testing, a nine-vector medication-risk algorithm, comprehensive pharmacist review, and structured recommendations to prescribers. Results: MTO participation was associated with a statistically significant reduction in total medical costs (pooled average treatment effect on the treated: −19.4%, −$246 per member per month [PMPM]; P < 0.001). The treatment effect was strongly duration-dependent, growing from −4.7% in the first three months to −31.9% (−$462 PMPM; P < 0.001) beyond nine months of program benefit. All care settings showed significant reductions: inpatient admissions −43.1% (P < 0.001), emergency department visits −41.3% (P < 0.001), and outpatient visits −28.3% (P < 0.001). Conclusion: Medication therapy optimization was associated with significant cost savings. Parallel trends validation and a pronounced dose-response relationship support a causal interpretation. Short-duration evaluations are likely to substantially underestimate the full economic value of an MTO program.

  • Open Access

    Improving Models to Predict Care Utilization Using Machine Learning: Retrospective Observational Study

    by Christopher Kitchen, Talan Zhang, Klaus Lemke, Chintan Pandya, Hadi Kharrazi, Jonathan P Weiner

    Background: The use of artificial intelligence and machine learning (ML) tools is now common in the advancement of health care services and clinical risk estimation. Legacy systems make use of highly informative feature sets developed from years of clinical expertise and research to estimate different outcomes, but only recently have they been tested against novel statistical approaches. One such system, the Johns Hopkins Adjusted Clinical Group (ACG) System, is a long-standing and widely used approach to categorizing clinical risk factors, and it is amenable to ML techniques. Objective: This study aims to test the ACG System using a contrasted area under the receiver operating characteristic (AUROC) and F 1 classification optimization strategy and compare its performance against traditional logistic regression methods. Assuming that selected ML algorithms can be tuned to enhance overall measures of performance, this would strengthen arguments for incorporating them into ACG-related workflows. Methods: Using a retrospective observational design, prospective year estimates of all-cause hospitalization and elevated total cost were modeled using a cross-validation framework. Patients with elevated costs were identified as those falling above the 95th percentile of total amounts billed, including pharmacy costs. Hyperparameter settings for XGBoost (Extreme Gradient Boosting), random forest, and elastic net were determined using average cross-validated performances for F 1 and AUROC in a grid search aimed at maximizing either statistic. Additional iterated cross-validation was used to compare point-estimated average AUROC and F 1 -scores between models, further decomposed by sensitivity, positive predictive value, and F -beta statistics. Results: There were 350,463 patients selected in 2019 from the Johns Hopkins Health System. Model features identified by the ACG System for predicting prospective year hospitalization and total cost were included in these analyses. Findings suggest small but statistically significant improvements in cross-validated AUROC and F 1 -scores over logistic regression, using either optimization strategy and XGBoost. Logistic models achieved average receiver operating characteristic values of 0.886 and 0.841 for cost and hospitalization, respectively, whereas XGBoost achieved 0.891 and 0.849, respectively. F 1 optimization yielded similar findings, with logistic models achieving 0.367 and 0.341 on average for hospitalization and cost, respectively, but XGBoost exceeded values for cost but not for hospitalization (0.411 and 0.328, respectively). Conclusions: The clinical implications of these findings and the effect of class imbalance on model calibration are explored, along with the limitations of these data and approach. The core finding is that logistic regression remains very well-suited to these tasks, especially in situations where the efficiency or interpretability of models is critical. Under conditions of imbalance, regressions tended to yield high-precision estimates for the outnumbered class. Nevertheless, the findings also underscore a diversity of suitable models depending on clinical use cases, each having its own tradeoffs for evaluating performance. As such, health systems must clearly identify the needs and expectations of a model before calibrating one for use.


  • Open Access

    Patterns of Telehealth Use Across the Cancer Care Continuum and Assessment of Patient and Geographic Factors Associated With Key Healthcare Outcomes: Retrospective Study

    by Kassandra I Alcaraz, Christopher Kitchen, Thomas Richards, Chintan J Pandya, Jonathan P Weiner, Elham Hatef

    Background: Although the use of telehealth has declined since the pandemic, it remains a popular mode of care delivery across the cancer care continuum. Understanding telehealth in the context of cancer care is essential, as its benefits and challenges may differ among diverse population groups and geographic areas. Objective: This study aimed to examine patterns of telehealth utilization across the cancer care continuum and to identify factors associated with the receipt of telehealth in a large patient population. This study also aimed to assess the telehealth's impact on key health care delivery outcomes. Methods: We used an annualized retrospective cohort design using patient data from the Johns Hopkins Health System (JHHS), a large regional academic health center in Maryland. The study analyzed electronic health record (EHR) data covering the period from January 1, 2019, to December 31, 2023. Chronic conditions were defined through the Johns Hopkins Adjusted Clinical Groups (ACG) System, which identifies comorbidities based on the International Classification of Diseases, Tenth Revision, Clinical Modification, codes in the electronic health record. In addition, we used publicly available geospatial data (eg, internet connectivity, rural–urban commuting area) to assess telehealth receipt associations. Statistical modeling, including generalized estimating equations, was used to evaluate variations in telehealth utilization and outcomes. Results: A total of 124,974 adult patients receiving cancer-related care at Johns Hopkins Health System were identified during the study period. Telehealth users were significantly older (52.2% aged ≥65 years, 19,942 patients) compared to nonusers (48.7%, 42,209 patients). In addition, these users were more likely to be male (45.4%, 17,365 patients vs 40.2%, 34,839 patients) and to identify as White (70.8%, 27,071 patients vs 64.7%, 56,122 patients). Telehealth users also had a higher prevalence of comorbidities, with 61.5% (23,503 patients) reporting 3 or more chronic conditions compared to 38.0% (33,000 patients) among nonusers. A positive correlation was noted between rural–urban commuting area codes and telehealth service utilization (ρ=0.36; P P P <0.05, respectively). Adjusted analyses indicated that concurrent telehealth use was associated with reduced odds of emergency department visits (0.916, 95% CI 0.884-0.948) and hospitalizations (0.830, 95% CI 0.799-0.863), acknowledging the potential influence of residual confounding. Conclusions: Telehealth has emerged as a crucial mode of care delivery for patients with complex conditions such as cancer. Understanding usage patterns and factors influencing telehealth across the cancer care continuum, including geographic barriers, is vital to optimizing its implementation and ensuring health care systems meet the diverse needs of patients with cancer in a value-based care environment.


  • Open Access

    Assessing the Impact of Computable Type 2 Diabetes Phenotypes on Predicting Healthcare Utilization Using Electronic Health Records and Administrative Claims

    by Priyanka D. Sood, Star Liu, Chintan Pandya, Hadi Kharrazi

    Background/Objectives: Type 2 Diabetes (T2D) computable phenotypes, which leverage electronic health records (EHRs) and administrative claims data, provide the basis for T2D population health research. Our study investigates how T2D phenotypes affect downstream healthcare utilization prediction, specifically inpatient (IP) and emergency room (ER) admissions. Methods: This study included 15,338 adult patients from a large academic medical center with both EHR and claims data from 2017 to 2019. We compared widely adopted and locally developed T2D phenotypes. EHR predictors and claims-based outcomes were used for utilization prediction. Models were developed using a 70/30 training-and-test split over 100 iterations. Mean area under the curve (AUC), odds ratios (ORs), positive predictive values, and negative predictive values were reported. Results: Models had comparable performance in concurrent predictions. Impact of phenotypic variation impact was more apparent in prospective predictions. The CMS Chronic Conditions Data Warehouse (CCW) phenotype was more discriminatory in predicting concurrent IP and ER admissions (AUCs of 0.80 and 0.74) than prospective IP and ER visits (0.70 and 0.73) in 2019. Conclusions: Our study demonstrated how phenotypic variations and data sources impact healthcare utilization prediction in T2D patients. Furthermore, we highlight the significance of phenotype selection for targeted T2D population health initiatives and management strategies.


  • Latent Class Analysis of Social Needs in Medicaid Population and Its Impact on Risk Adjustment Models

    by Chintan J. Pandya, JunBo BS Wu, Elham Hatef, Hadi Kharrazi

    Background: A growing number of US states are implementing programs to address the social needs (SNs) of their Medicaid populations through managed care contracts. Incorporating SN might also improve risk adjustment methods used to reimburse Medicaid providers. Objectives: Identify classes of SN present within the Medicaid population and evaluate the performance improvement in risk adjustment models of health care utilization and cost after incorporating SN classes. Research Design: A secondary analysis of Medicaid patients during the years 2018 and 2019. Latent class analysis (LCA) was used to identify SN classes. To evaluate the impact of SN classes on measures of hospitalization, emergency (ED) visits, and costs, logistic and linear regression modeling for concurrent and prospective years was used. Model performance was assessed before and after incorporating these SN classes to base models controlling for demographics and comorbidities. Subjects: 262,325 Medicaid managed care program patients associated with a large urban academic medical center. Results: 7.8% of the study population had at least one SN, with the most prevalent being related to safety (3.9%). Four classes of SN were determined to be optimal based on LCA, including stress-related needs, safety-related needs, access to health care–related needs, and socioeconomic status–related needs. The addition of SN classes improved the performance of concurrent base models’ AUC (0.61 vs. 0.58 for predicting ED visits and 0.61 vs. 0.58 for projecting hospitalizations). Conclusions: Incorporating SN clusters significantly improved risk adjustment models of health care utilization and costs in the study population. Further investigation into the predictive value of SN for costs and utilization in different Medicaid populations is merited.


  • Open Access

    Patterns of Morbidity Across the Lifespan

    by Klaus W. PhD Lemke, Christopher B. Forrest, Bruce A. Leff, Cynthia M. Boyd, Kimberly A. Gudzune, Craig E. Md Pollack, Chintan J. PhD Pandya, Jonathan P. DrPH Weiner

    Background: Classification systems to segment such patients into subgroups for purposes of care management and population analytics should balance administrative simplicity with clinical meaning and measurement precision. Objective: To describe and empirically apply a new clinically relevant population segmentation framework applicable to all payers and all ages across the lifespan. Research Design and Subjects: Cross-sectional analyses using insurance claims database for 3.31 Million commercially insured and 1.05 Million Medicaid enrollees under 65 years old; and 5.27 Million Medicare fee-for-service beneficiaries aged 65 and older. Measures: The “Patient Need Groups” (PNGs) framework, we developed, classifies each person within the entire 0–100+ aged population into one of 11 mutually exclusive need-based categories. For each PNG segment, we documented a range of clinical and resource endpoints, including health care resource use, avoidable emergency department visits, hospitalizations, behavioral health conditions, and social need factors. Results: The PNG categories included: (1) nonuser; (2) low-need child; (3) low-need adult; (4) low-complexity multimorbidity; (5) medium-complexity multimorbidity; (6) low-complexity pregnancy; (7) high-complexity pregnancy; (8) dominant psychiatric/behavioral condition; (9) dominant major chronic condition; (10) high-complexity multimorbidity; and (11) frailty. Each PNG evidenced a characteristic age-related trajectory across the full lifespan. In addition to offering clinically cogent groupings, large percentages (29%–62%) of patients in two pregnancy and high-complexity multimorbidity and frailty PNGs were in a high-risk subgroup (upper 10%) of potential future health care utilization. Conclusions: The PNG population segmentation approach represents a comprehensive measurement framework that captures and categorizes available electronic health care data to characterize individuals of all ages based on their needs.


  • Validity Properties of a Self-reported Modified Frailty Phenotype Among People With HIV in Clinical Care in the United States

    by Stephanie A. Ruderman, Allison R. Rn Webel, Amanda L. PhD Willig, Lydia N. Drumright, Annette L. Fitzpatrick, Michelle C. Odden, John D. Cleveland, Greer Burkholder, Christine H. Rn Davey, Julia Fleming, et al.

    Modifications to Fried's frailty phenotype (FFP) are common. We evaluated a self-reported modified frailty phenotype (Mod-FP) used among people with HIV (PWH). Among 522 PWH engaged in two longitudinal studies, we assessed validity of the four-item Mod-FP compared with the five-item FFP. We compared the phenotypes via receiver operator characteristic curves, agreement in classifying frailty, and criterion validity via association with having experienced falls. Mod-FP classified 8% of PWH as frail, whereas FFP classified 9%. The area under the receiver operator characteristic curve for Mod-FP classifying frailty was 0.93 (95% CI = 0.91–0.96). We observed kappa ranging from 0.64 (unweighted) to 0.75 (weighted) for categorizing frailty status. Both definitions found frailty associated with a greater odds of experiencing a fall; FFP estimated a slightly greater magnitude (i.e., OR) for the association than Mod-FP. The Mod-FP has good performance in measuring frailty among PWH and is reasonable to use when the gold standards of observed assessments (i.e., weakness and slowness) are not feasible.


  • Impact of Social Needs in Electronic Health Records and Claims on Health Care Utilization and Costs Risk-Adjustment Models Within Medicaid Population

    by Chintan J. Pandya, Elham Hatef, JunBo Wu, Thomas Richards, Jonathan P. Weiner, Hadi Kharrazi

    Patients enrolled in Medicaid have significantly higher social needs (SNs) than others. Using claims and electronic health records (EHRs) data, managed care organizations (MCOs) could systemically identify high-risk patients with SNs and develop population health management interventions. Impact of SNs on models predicting health care utilization and costs was assessed. This retrospective study included claims and EHRs data on 39,267 patients younger than age 65 years who were continuously enrolled during 2018–2019 in a Medicaid-managed care plan. SN marker was developed suggesting presence of International Classification of Diseases, 10th revision codes in any of the 5 SN domains. Impact of SN marker was compared across demographic and 2 diagnosis-based (ie, Charlson and Adjusted Clinical Groups risk score) prediction models of emergency department (ED) visit and hospitalizations, and total, medical, and pharmacy costs. After combining data sources, prevalence of documented SN marker increased from 11% and 13% to 18% of the study population across claims, EHRs, and both combined, respectively. SN marker improved predictions of demographic models for all utilization and total costs outcomes (area under the curve [AUC] of ED model increased from 0.57 to 0.61 and R 2 of total cost model increased from 10.9 to 12.2). In both diagnosis-based models, adding SN marker marginally improved outcomes prediction (AUC of ED model increased from 0.65 to 0.66). This study demonstrated feasibility of using claims and EHRs data to systematically capture SNs and incorporate in prediction models that could enable MCOs and policy makers to adjust and develop effective population health interventions.


  • Open Access

    QOLP-26. PATIENT REPORTED SOCIAL FUNCTION AND SURVIVAL IN GLIOMA PATIENTS

    by Sara Hardy, Chintan Pandya, Nimish Mohile, Michelle Janelsins, Michael Milano

    PURPOSE: Research among patients with cancer suggests that health related quality of life (HRQOL) may be more predictive of survival than performance status. Social function is a HRQOL outcome influenced by both physical and mental health. To our knowledge, no work has analyzed the potential association between survival and social function in patients with brain tumors. METHODS: In the SEER Medicare Health Outcomes Survey, 158 patients were identified with 1) diagnosis of glioma between 1976 and 2013 2) no other cancer diagnosis 3) at least one post-diagnosis HRQOL survey. We examined the relationship between social function and mortality using a multivariable Cox proportional hazard model. We also examined factors correlated with social function score using linear regression. RESULTS: At last follow up, 48% of the patients had died, 53% were female, 59% had trouble with ≥1 ADL, 53% were married, 27% had glioblastoma, 74% were white, and 32% had no reported comorbidities. Median time from cancer diagnosis to survey was 79 months and median age at survey was 60 years. For patients alive at last follow-up, there was a difference of >5 points for the social function subscale (38.2 vs 30.6) compared to those who died during the median 163 month follow up interval. On multivariable Cox proportion hazard model adjusting for covariates, higher social function scores were significantly associated with improved survival (5 point increase in score, HR 0.86, p = 0.0029). Worse social function was associated with patient-reported neurologic deficits in vision and speech and report of depression, but not marital status, sex, race, or patient-reported income. DISCUSSION: Patient-reported social function score on post-diagnosis surveys, even after accounting for important clinical factors, was significantly associated with survival. The impact of patient reported social function in those with glioma should be further examined in confirmatory longitudinal studies.